Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 31:7:19.
doi: 10.1186/s13293-016-0073-y. eCollection 2016.

Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists

Pamela Ouyang  1 , Nanette K Wenger  2 , Doris Taylor  3 , Janet W Rich-Edwards  4 , Meir Steiner  5 , Leslee J Shaw  2 , Sarah L Berga  6 , Virginia M Miller  7 , Noel Bairey Merz  8
Affiliations
Review

Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists

Pamela Ouyang et al. Biol Sex Differ. .

Abstract

Background: In 2001, the Institute of Medicine's (IOM) report, "Exploring the Biological Contributions to Human Health: Does Sex Matter?" advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice. Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes. There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction.

Methods: The Society for Women's Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan. References for methods and strategy details are provided to gather and evaluate this information. Some items comprise robust measures; others are in development.

Results: To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women. Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy. Other factors that differentially affect women's CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control. Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered. Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected. These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease. Lack of sex-specific knowledge contributes to the CVD health disparities that women face.

Conclusions: The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.

Keywords: Cardiovascular disease; Sex-specific; Women.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Algorithm on assessment of ovarian function
Fig. 2
Fig. 2
Women are underrepresented in cardiovascular clinical trials [204]
Fig. 3
Fig. 3
Cycle of quality to improve the care of women with CVD
Fig. 4
Fig. 4
Number of articles reporting data on women by year [221]
See this image and copyright information in PMC

References

    1. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) national quality improvement initiative. J Am Coll Cardiol. 2005;45(6):832–7. doi: 10.1016/j.jacc.2004.11.055. - DOI - PubMed
    1. Chou AF, Wong L, Weisman CS, Chan S, Bierman AS, Correa-de-Araujo R, et al. Gender disparities in cardiovascular disease care among commercial and medicare managed care plans. Womens Health Issues. 2007;17(3):139–49. doi: 10.1016/j.whi.2007.03.004. - DOI - PubMed
    1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69–171. doi: 10.1161/CIRCULATIONAHA.106.179918. - DOI - PubMed
    1. Jacobs AK, Johnston JM, Haviland A, Brooks MM, Kelsey SF, Holmes DR, Jr, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol. 2002;39(10):1608–14. doi: 10.1016/S0735-1097(02)01835-1. - DOI - PubMed
    1. Malenka DJ, Wennberg DE, Quinton HA, O'Rourke DJ, McGrath PD, Shubrooks SJ, et al. Gender-related changes in the practice and outcomes of percutaneous coronary interventions in Northern New England from 1994 to 1999. J Am Coll Cardiol. 2002;40(12):2092–101. doi: 10.1016/S0735-1097(02)02605-0. - DOI - PubMed

LinkOut - more resources